1 2 "The first fully A.I.-generated drug enters clinical trials in human patients"
A systematic review of 76 different clinical trials looking at the risk of gallbladder disease for people taking GLP-1 agonists showed that there was an increase in risk for the development of gallbladder disease when taken at higher doses for long periods of time
A more recent randomized, double-blind, placebo-controlled study in 30 patients with type 2 diabetes found that intravenous infusion of 600 mg of lipoic acid improved the response to the endothelium-dependent vasodilator acetylcholine but not to the endothelium-independent vasodilator, glycerol trinitrate (63)
Neurochem Res 43(9):17661778
But again, Joe's done it all, so he doesn't lose his cool, and Gerry's a pro, and we pulled it off
Most providers choose based on: Patient tolerance Weight-loss goals Cost considerations Medical history Who Should Consider Semaglutide